No vacillation on HPV vaccination

• Autores: Douglas Sipp, Ian H. Frazer, John J. E. Rasko
• Localización: Cell, ISSN 0092-8674, Vol. 172, Nº. 6, 2018 (Ejemplar dedicado a: The Microbial Word), págs. 1163-1167
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Evidence of the safety and protective benefits of human papillomavirus virus (HPV) vaccines as an anti-cancer measure is overwhelming. However, vaccine uptake varies widely across countries and falls short of levels needed to achieve population immunity. We highlight policy measures that would help ensure greater worldwide coverage and save lives.